* Note Please find further information in the consolidated financial statements. 1 8th August, 2019 Subject: Management Discussion & Analysis (MD&A) for the 2nd quarter of 2019 Attention: The
* Note Please find further information in the consolidated financial statements. 1 7th August, 2018 Subject: Management Discussion & Analysis (MD&A) for the 2nd quarter of 2018 Attention: The
* Note Please find further information in the consolidated financial statements. 1 13th November, 2018 Subject: Management Discussion & Analysis (MD&A) for the 3rd quarter of 2018 Attention: The
* Note Please find further information in the consolidated financial statements. 1 12th November, 2019 Subject: Management Discussion & Analysis (MD&A) for the 3rd quarter of 2019 Attention: The
* Note Please find further information in the consolidated financial statements. 1 May 13th, 2020 Subject: Management Discussion & Analysis (MD&A) for the 1st quarter of 2020 Attention: The President
for public offerings. The issuers must prepare financial statements in accordance with financial reporting standards while having no record of failure to file with the SEC their financial statements or
separate financial statements of the Company as at March 31, 2017 (according to the consolidated financial statements of the Company, the Company’s current ratio and debt to equity ratio are 0.24 and 1.58
period at the ended of 30 September 2017 as follows. The operation results of the Company and the Company’s subsidiaries in the consolidated financial statements for the period ended September 30, 2017
financial statements and performance of the Company and the Company’s for the first quarter ending 31 March 2019, which has already been examined by the Company’s auditor, the results can be summarized as